Cargando…

Mechanisms of resistance to chemotherapeutic and anti-angiogenic drugs as novel targets for pancreatic cancer therapy

Pancreatic cancer remains one of the most lethal and poorly understood human malignancies and will continue to be a major unsolved health problem in the 21(st) century. Despite efforts over the past three decades to improve diagnosis and treatment, the prognosis for patients with pancreatic cancer i...

Descripción completa

Detalles Bibliográficos
Autores principales:	Tamburrino, Anna, Piro, Geny, Carbone, Carmine, Tortora, Giampaolo, Melisi, Davide
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2013
Materias:	Pharmacology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3639407/ https://www.ncbi.nlm.nih.gov/pubmed/23641216 http://dx.doi.org/10.3389/fphar.2013.00056

Ejemplares similares

Toll-Like Receptor 9 Agonists for Cancer Therapy
por: Melisi, Davide, et al.
Publicado: (2014)

Pancreatic Cancer and Obesity: Molecular Mechanisms of Cell Transformation and Chemoresistance
por: Cascetta, Priscilla, et al.
Publicado: (2018)

An angiopoietin-like protein 2 autocrine signaling promotes EMT during pancreatic ductal carcinogenesis
por: Carbone, Carmine, et al.
Publicado: (2014)

KRAS-Dependency in Pancreatic Ductal Adenocarcinoma: Mechanisms of Escaping in Resistance to KRAS Inhibitors and Perspectives of Therapy
por: Gurreri, Enrico, et al.
Publicado: (2023)

Angiopoietin-Like Proteins in Angiogenesis, Inflammation and Cancer
por: Carbone, Carmine, et al.
Publicado: (2018)

Immunogenic Cell Death: An Emerging Target in Gastrointestinal Cancers
por: Chiaravalli, Marta, et al.
Publicado: (2022)

Intraductal Pancreatic Mucinous Neoplasms: A Tumor-Biology Based Approach for Risk Stratification
por: Nasca, Vincenzo, et al.
Publicado: (2020)

A circulating T(H)2 cytokines profile predicts survival in patients with resectable pancreatic adenocarcinoma
por: Piro, Geny, et al.
Publicado: (2017)

EMT and Treatment Resistance in Pancreatic Cancer
por: Gaianigo, Nicola, et al.
Publicado: (2017)

Pancreatic Cancer Patient-Derived Organoid Platforms: A Clinical Tool to Study Cell- and Non-Cell-Autonomous Mechanisms of Treatment Response
por: Piro, Geny, et al.
Publicado: (2021)

Gastrointestinal Cancer Patient Nutritional Management: From Specific Needs to Novel Epigenetic Dietary Approaches
por: Cencioni, Chiara, et al.
Publicado: (2022)

Organoid-Transplant Model Systems to Study the Effects of Obesity on the Pancreatic Carcinogenesis in vivo
por: Lupo, Francesca, et al.
Publicado: (2020)

Revising PTEN in the Era of Immunotherapy: New Perspectives for an Old Story
por: Piro, Geny, et al.
Publicado: (2019)

HOX Genes Family and Cancer: A Novel Role for Homeobox B9 in the Resistance to Anti-Angiogenic Therapies
por: Contarelli, Serena, et al.
Publicado: (2020)

Intratumoral injection of TLR9 agonist promotes an immunopermissive microenvironment transition and causes cooperative antitumor activity in combination with anti-PD1 in pancreatic cancer
por: Carbone, Carmine, et al.
Publicado: (2021)

Antimicrobial Peptide Reverses ABCB1-Mediated Chemotherapeutic Drug Resistance
por: Luo, Xiaofang, et al.
Publicado: (2020)

Editorial: Ovarian cancer-targeted medication: PARP inhibitors, anti-angiogenic drugs, immunotherapy, and more
por: Wang, Zhi-Bin, et al.
Publicado: (2023)

Chemotherapeutic drugs for soft tissue sarcomas: a review
por: Tian, Zhichao, et al.
Publicado: (2023)

Computational drug repositioning for peripheral arterial disease: prediction of anti-inflammatory and pro-angiogenic therapeutics
por: Chu, Liang-Hui, et al.
Publicado: (2015)

Therapeutic Effect and Mechanism of Bushen-Jianpi-Jiedu Decoction Combined with Chemotherapeutic Drugs on Postoperative Colorectal Cancer
por: Yang, Meng-Die, et al.
Publicado: (2021)

Antioxidant, Anti-Inflammatory and Anti-Angiogenic Properties of Citrus lumia Juice
por: Smeriglio, Antonella, et al.
Publicado: (2020)

Immunoevolution of mouse pancreatic organoid isografts from preinvasive to metastatic disease
por: Filippini, Dea, et al.
Publicado: (2019)

Cleavage Stimulation Factor Subunit 2: Function Across Cancers and Potential Target for Chemotherapeutic Drugs
por: Feng, Linfei, et al.
Publicado: (2022)

Molecular features of interaction between VEGFA and anti-angiogenic drugs used in retinal diseases: a computational approach
por: Platania, Chiara B. M., et al.
Publicado: (2015)

Chemotherapeutic and targeted drugs-induced immunogenic cell death in cancer models and antitumor therapy: An update review
por: Zhai, Jiaqi, et al.
Publicado: (2023)

PTEN in Lung Cancer: Dealing with the Problem, Building on New Knowledge and Turning the Game Around
por: Gkountakos, Anastasios, et al.
Publicado: (2019)

Reactive resistance to anti-angiogenic drugs
por: Bousquet, Guilhem, et al.
Publicado: (2015)

Erratum: Molecular features of interaction between VEGFA and anti-angiogenic drugs used in retinal diseases: a computational approach
Publicado: (2016)

Targeting Angiogenesis in Breast Cancer: Current Evidence and Future Perspectives of Novel Anti-Angiogenic Approaches
por: Ayoub, Nehad M., et al.
Publicado: (2022)

Kinome-Wide siRNA Screening Identifies Src-Enhanced Resistance of Chemotherapeutic Drugs in Triple-Negative Breast Cancer Cells
por: Tzeng, Yen-Dun Tony, et al.
Publicado: (2018)

Anti-angiogenic Therapy in Cancer: Downsides and New Pivots for Precision Medicine
por: Lupo, Gabriella, et al.
Publicado: (2017)

15, 16-Dihydrotanshinone I Inhibits Hemangiomas through Inducing Pro-apoptotic and Anti-angiogenic Mechanisms in Vitro and in Vivo
por: Cai, Yihong, et al.
Publicado: (2018)

Mechanisms of resistance to anti-angiogenic treatments
por: Pezzella, Francesco
Publicado: (2019)

Lung and Gut Microbiota as Potential Hidden Driver of Immunotherapy Efficacy in Lung Cancer
por: Carbone, Carmine, et al.
Publicado: (2019)

Suppression of CD13 Enhances the Cytotoxic Effect of Chemotherapeutic Drugs in Hepatocellular Carcinoma Cells
por: Ji, Shengping, et al.
Publicado: (2021)

Dual-Ligand-Modified Liposomes Co-Loaded with Anti-Angiogenic and Chemotherapeutic Drugs for Inhibiting Tumor Angiogenesis and Metastasis
por: Wang, Fangqing, et al.
Publicado: (2021)

Anti-angiogenic therapy in ovarian cancer: Current understandings and prospects of precision medicine
por: Mei, Chao, et al.
Publicado: (2023)

Anti-Inflammatory and Anti-Angiogenic Aattributes of Moringa olifera Lam. and its Nanoclay-Based Pectin-Sericin films
por: Buabeid, Manal Ali, et al.
Publicado: (2022)

Involvement of P-gp on Reversing Multidrug Resistance Effects of 23-Hydroxybetulinic Acid on Chemotherapeutic Agents
por: Liu, Zhihao, et al.
Publicado: (2021)

Resistance Mechanisms to Anti-angiogenic Therapies in Cancer
por: Haibe, Yolla, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_2becphepctv02u6ue0ediul97l